New wound dressing compositions
AssigneeSystagenix Wound Management (US), Inc.
InventorsRachel Louise Clark, Breda Mary Cullen, Lindsay Matheson
Life of this patent
Estimating the term…
Abstract
A wound dressing composition comprising a non-viable cell lysate or releasate derived from a hepatocyte cell or an inflammatory cell such as a macrophage. Also provided are wound dressings comprising such compositions, methods of making such compositions, and the use of such compositions for the treatment of wounds.
Claims23
A wound dressing composition comprising a non-viable cell lysate or releasate derived from an inflammatory cell.
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
A process for the production of a wound dressing comprising the steps of lysing hepatocyte or macrophage cells to form a lysate, and dispersing the lysate in or on a pharmaceutically acceptable carrier.
A method of treating a wound, comprising:
- dispersing a non-viable material from a hepatocyte or a macrophage cell on a pharmaceutically acceptable carrier to form a wound dressing;
- and
- applying the wound dressing to the wound.
A wound dressing, comprising a non-viable material from a hepatocyte dispersed on a pharmaceutically-acceptable vehicle.
Dependencies are inferred from the claim text.